Concomittant use with ephinephrine may cause mydriasis additive systemic effects with systemic usuage of beta-blockers and catecholamine-depletors(reserpine).

Ocular stinging,burning,blepharoconjuntivitis,decreased heart rate,decreased B.P.,indocycitis, headache,transcient ataxia,dizziness,lethargy,decreased corneal sensitivity,urticaria and puritus.

Broncial asthmal/severe COPD sinus bradycardia second and third degree heart block overt catdiac failure cardiogenic shock hypersensitivity.

Special precautions:

In patients with acute respiratory disorders excercise caution. Continued myocardiac depression may lead to cardiac failure. Look for the clue and withdraw the medicament if required. Avoid contamination with the nozzle tip. Caution in diabetes melitus,pregnancy and lactation.

Approved by (DCI) Drug Controller  GENERAL -  India  For Marketing                                                                                   (Ref- IDMA Publication)

Indication:

Lowering of IOP in chrinic open-angle glaucoma or ocular hypertension.

Dosage: Usual dose:

instill 1 drop in the affected eye(s) once or twice a day.

Refer -Atenolol- Beta-adrenergic blocking agents

Refer- Atenolol- Beta-adrenergic blocking agents

Not applicable

Refer - Atenolol- Beta-adrenergic blocking agents